Targeting vulnerability in B-cell development leads to novel drug combination for leukemia
St. Jude Children's Research HospitalRecent work by St. Jude Children’s Research Hospital scientists discovered which tumor cells resist treatment and why. By characterizing B-cells’ developmental stages, they designed and tested a drug combination to effectively treat resistant B-cell leukemia.